0001493152-25-028000.txt : 20251216 0001493152-25-028000.hdr.sgml : 20251216 20251216171106 ACCESSION NUMBER: 0001493152-25-028000 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20251216 DATE AS OF CHANGE: 20251216 EFFECTIVENESS DATE: 20251216 FILER: COMPANY DATA: COMPANY CONFORMED NAME: FibroBiologics, Inc. CENTRAL INDEX KEY: 0001958777 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences EIN: 863329066 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-567052 FILM NUMBER: 251576406 BUSINESS ADDRESS: STREET 1: 455 E. MEDICAL CENTER BLVD STREET 2: SUITE 300 CITY: HOUSTON STATE: TX ZIP: 77598 BUSINESS PHONE: 281-671-5150 MAIL ADDRESS: STREET 1: 455 E. MEDICAL CENTER BLVD SUITE 300 STREET 2: SUITE 300 CITY: HOUSTON STATE: TX ZIP: 77598 FORMER COMPANY: FORMER CONFORMED NAME: FibroBiologics Inc. DATE OF NAME CHANGE: 20221216 D 1 primary_doc.xml X0708 D LIVE 0001958777 FibroBiologics, Inc. 455 E. MEDICAL CENTER BLVD, SUITE 300 HOUSTON TX TEXAS 77598 281 671-5150 DELAWARE FibroBiologics LLC Fibrobiologics, Inc. FibroBiologics Inc. Corporation true 2021 Pete O'Heeron 455 E. Medical Center Blvd, Suite 300 Houston TX TEXAS 77598 Executive Officer Director Chairman, Founder and Chief Executive Officer Stacy Coen 455 E. Medical Center Blvd, Suite 300 Houston TX TEXAS 77598 Director Robert Hoffman 455 E. Medical Center Blvd, Suite 300 Houston TX TEXAS 77598 Director Matthew Link 455 E. Medical Center Blvd, Suite 300 Houston TX TEXAS 77598 Director Victoria Niklas 455 E. Medical Center Blvd, Suite 300 Houston TX TEXAS 77598 Director Richard C. Cilento 455 E. Medical Center Blvd, Suite 300 Houston TX TEXAS 77598 Director Jason D. Davis 455 E. Medical Center Blvd, Suite 300 Houston TX TEXAS 77598 Executive Officer Chief Financial Officer Pharmaceuticals Decline to Disclose 06b false 2025-12-14 false true true true false 0 H.C. Wainwright & Co., LLC 000000375 None None 430 Park Avenue 3rd Floor New York NY NEW YORK 10022 CA CALIFORNIA FL FLORIDA IL ILLINOIS NY NEW YORK true 1725001 1725001 0 Includes warrants to purchase 5,227,275 shares of the issuer's common stock (exercise price of $0.33 per share). false 4 329888 0 Represents a 7% fee; a 1% management fee; reimbursement of non-accountable expenses of $25,000 and clearing fees of $15,950; and placement agent warrants to purchase 365,909 shares (exercise price of $0.4125 per share). 0 The issuer intends to use the net proceeds from this offering for working capital and general corporate purposes. false FibroBiologics, Inc. /s/ Ruben A. Garcia Ruben A. Garcia General Counsel 2025-12-16